United States Longevity Therapeutics Industry Intelligence Report Insights: Market Trends, Leaders & Opportunities

The longevity therapeutics market was valued at US$21.74 billion in 2023 and grew to US$23.24 billion in 2024. It is projected to reach US$43.72 billion by 2033, expanding at a CAGR of 7.8% during the forecast period from 2025 to 2033.

DataM Intelligence unveils its latest report on the "Longevity Therapeutics Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

According to WHO data from February 2025, the global population aged 60 and above is projected to rise from 1.1 billion in 2023 to 1.4 billion by 2030. This trend is accelerating not only in high-income countries but even more rapidly in developing regions, where better healthcare and improved living standards are contributing to longer life expectancy and a larger elderly population.

In the U.S., major cardiovascular risk factors are set to rise sharply by 2060, with diabetes projected to affect 55 million people. Longevity therapies targeting age-related cellular damage are emerging to improve heart health. In February 2025, Junevity, a biotech startup developing "Cell Reset" therapeutics, launched with $10M seed funding, reinforcing North America's lead in the global longevity therapeutics market.

Cardiovascular diseases were the leading cause of death, claiming over 19 million lives, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million, including diabetes-related kidney disease deaths). Together, these four groups account for 80% of all premature NCD deaths, highlighting their significant impact on global mortality and morbidity.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/longevity-therapeutics-market?kb

Key Drivers

In April 2024, the Longevity India Initiative by IISc launched to advance aging research and promote healthy lifespans through a multidisciplinary approach, strengthening India's role in the global longevity therapeutics market.

List of Top Key Player:

The major global players in the longevity therapeutics market include Decode Age, Zeroharm, Gataca, Longevity by Nature, ProHealth, Inc., Xandro Lab., NanoSPACE, AgeX Therapeutics, Inc., T.A. SCIENCES, and Elysium Health, Inc., among others.

Global Longevity Therapeutics Market - Competitive Landscape (Emerging Players)

The emerging players in the longevity therapeutics market include Longeveron, and Stealth BioTherapeutics Inc., among others.

Industry Developments:

In May 2025, Jupiter Neurosciences, Inc. expanded into the consumer wellness market by launching Nugevia, a new line of performance and longevity supplements, available direct-to-consumer in Q3 2025.

In April 2025, I Peace, Inc., a leader in iPSC technology, introduced personalized stem cell production and longevity-focused rejuvenation therapies in the U.S., making advanced age-reversal technology more widely accessible.

In September 2024, Longevity Biomedical, Inc., focused on extending human healthspan, announced a business combination with FutureTech II Acquisition Corp. (SPAC).

In August 2024, Orgenesis Inc. partnered with Harley Street Healthcare Group (HSHG) to launch a global longevity and wellness initiative, combining expertise in cell and gene therapies with personalized healthcare services.

Forecast Projection:

The Global Longevity Therapeutics Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Longevity Therapeutics Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=longevity-therapeutics-market

Key Segmentation:

D!etary supplements to hold 58.4% of 2024 market

By Application: (Senescence Inhibition, Cardiovascular Diseases, Cancer, Others)

By Distribution Channels: (Pharmacies, Online, Retail Stores)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Longevity Therapeutics Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/longevity-therapeutics-market?kb

FAQ's

Q1: How fast is the Longevity Therapeutics Market expected to grow in the coming years?

A: The market is forecast to expand at a robust CAGR of 7.8% between 2025 and 2032, signaling strong global growth and investment potential.

Q2: Which regions are dominating the Longevity Therapeutics Market and which are fastest-growing?

A: North America: 48.7%, Asia-Pacific: 21.4% of 2024 market

Q3: What factors are fueling the Longevity Therapeutics Market's growth across regions?

A: Growth is propelled by increasing demand, strategic initiatives by key players, and untapped opportunities in emerging markets, helping companies maximize revenue potential.

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.